For example, faricimab (Vabysmo, Genentech/Roche) is reported with HCPCS code J2777, with 60 units representing the 6 mg/0.05 mL administered per eye
However, no research directly compares continuous use versus cycling protocols (such as 12 weeks on, 4-8 weeks off), leaving optimal long-term strategies somewhat uncertain
However, it's important to note that most of the current understanding is based on preliminary research, primarily from animal studies
white arrow indicates normal neuron)
The rationale for cycling includes allowing receptor resensitization and providing observation periods to assess maintained benefits
Two months since last injection and no improvement in face its worse